The changing spectrum of neonatal infectious disease

L R W Plano1

  • 1Department of Pediatrics, University of Miami, Miller School of Medicine, Miami, FL 33136, USA. lplano@med.miami.edu

Insights

Neonatal infectious disease spectrum is shifting due to medical advances, increasing survival rates for premature infants. This change heightens the risk of infections from previously non-pathogenic organisms in vulnerable newborns.

Area of Science:

  • Neonatal Medicine
  • Infectious Diseases
  • Microbiology

Background:

  • Advances in neonatal care have led to increased survival rates for extremely premature infants.
  • This success has altered the landscape of neonatal infectious diseases.
  • Very low birth weight infants face heightened risks from a broader range of pathogens.

Purpose of the Study:

  • To review the evolving patterns of neonatal infectious diseases.
  • To highlight the changing role of microorganisms as pathogens in neonates.
  • To emphasize the impact of medical practices and microbial adaptation on infection spectrum.

Main Methods:

  • Literature review focusing on bacterial and fungal neonatal infections.
  • Analysis of historical trends and current practices in neonatal care.
  • Examination of pathogen evolution and adaptation under selective pressures.

Main Results:

  • The spectrum of neonatal infections has significantly changed over time.
  • Organisms previously considered benign are now recognized as common pathogens.
  • Very low birth weight infants are particularly susceptible to these evolving threats.

Conclusions:

  • Understanding the changing spectrum of neonatal infections is crucial for effective management.
  • Therapeutic strategies must consider neonate maturity, age, and intensity of care.
  • The review primarily addresses bacterial and fungal infections, with limited focus on viral agents.

Related Concept Videos

Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...